See associations below
|I AE1/AE3||cytokeratin cocktail, PAN(AE1/AE3)|
|I BER EP4||epithelial antigen|
|I CEA||carcinoembryonic antigen|
|I CD56||NK cells|
|I CHROGRAN||chromogranin A|
|I CK HMW||Cytokeratin high molecular weight; 34BE12|
|I CK5/6||Cytokeratin 5/6, squamous, mesothelial|
|I CK7||Cytokeratin 7, 54kD|
|I CK19*||cytokeratin 19|
|I CK20||Cytokeratin 20|
|I P53||p53 tumor suppressor gene protein|
|I P63NU||p63 nuclear, tumor suppressor gene protein|
|I TTF1||Thyroid Transcription Factor-1|
|I WT1||Wilm's tumor|
* performed by affiliate laboratory
Technical component (TC) available for all markers
Send reports, history and differential diagnosis
Ship ambient. In extreme hot weather, ship with a cool pack.
Inadequate fixation; Improper labeling
Marker and tissue specific
Results are reviewed by a board-certified pathologist to determine if tissues are positive or negative for the marker. These results may be used to assist in determining appropriate patient therapy or treatment. Immunohistochemistry combines the principles of histochemistry with the high degree of molecular specificity of the antibody-antigen reaction. The use of an enhanced-polymer detection system provides many benefits, including increased sensitivity, fewer procedural steps as compared to conventional techniques, and a reduction in non-specific background staining.
MPLN offers a range of markers by Immunohistochemistry including hematologic, tissue specific, infectious agents and proliferation antigens.